FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Alkem Laboratories IPO and Healthcare Global IPO.
Alkem Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Healthcare Global IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Alkem Laboratories IPO | Healthcare Global IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Edelweiss Financial Services Ltd J.P. Morgan India Private Limited Nomura Financial Advisory And Securities (India) Pvt Ltd |
Edelweiss Financial Services Ltd Goldman Sachs (India) Securities Private Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd Kotak Mahindra Capital Company Limited Yes Bank Limited |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Alkem Laboratories IPO is up to ₹1,349.61 Cr whereas the issue size of the Healthcare Global IPO is up to ₹649.64 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of Healthcare Global IPO is ₹218.00 per share.
Alkem Laboratories IPO | Healthcare Global IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹1,020.00 per share | ₹205.00 per share |
Issue Price (Upper) | ₹1,050.00 per share | ₹218.00 per share |
Issue Price (Final) | ₹1,050.00 per share | ₹218.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 14 shares | 65 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 1,28,53,442 shares | 2,98,00,000 shares |
Issue Size Total (Amount) | up to ₹1,349.61 Cr | up to ₹649.64 Cr |
Alkem Laboratories IPO opens on Dec 08, 2015, while Healthcare Global IPO opens on Mar 16, 2016. The closing date of Alkem Laboratories IPO and Healthcare Global IPO is Dec 10, 2015, and Mar 18, 2016, respectively.
Alkem Laboratories IPO | Healthcare Global IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Dec 08, 2015 | Mar 16, 2016 |
Issue Close | Dec 10, 2015 | Mar 18, 2016 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Alkem Laboratories IPO P/E ratio is , as compared to Healthcare Global IPO P/E ratio of .
Alkem Laboratories IPO | Healthcare Global IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 70.87% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 66.23% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 15.4%% |
In the Alkem Laboratories IPO retail investors (RII) are offered 43,94,086 shares while in Healthcare Global IPO retail investors are offered 43,94,086 shares. Qualified institutional buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 89,40,000 shares in Healthcare Global IPO.
Alkem Laboratories IPO | Healthcare Global IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 25,10,906 shares | 89,40,000 shares |
NII | 18,83,179 shares | 44,70,000 shares |
RII | 43,94,086 shares | 29,80,000 shares |
Employee | 2,98,913 shares | |
Others | ||
Total | 90,87,084 shares | 1,63,90,000 shares |
Alkem Laboratories IPO subscribed 44.29x in total, whereas Healthcare Global IPO subscribed 1.56x.
Alkem Laboratories IPO | Healthcare Global IPO | |
---|---|---|
QIB (times) | 57.19x | 2.36x |
NII (times) | 129.96x | 0.43x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.17x | 0.83x |
Employee (times) | 0.67x | |
Other (times) | ||
Total (times) | 44.29x | 1.56x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|